| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC7183 | Panobinostat(LBH589) Featured | Panobinostat(LBH-589) is a broad-spectrum HDAC inhibitor; low nanomolar concentrations (IC50=5-20 nM) of LBH589 induced cell-cycle arrest, apoptosis, and histone (H3K9 and H4K8) hyperacetylation in MOLT-4 and Reh cell. |
|
| DC9876 | Pantoprazole | Pantoprazole is a proton pump inhibitor used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease. |
|
| DC9135 | Pantoprazole Sodium | Pantoprazole sodium salt(SKF96022; Protonix) is a proton pump inhibitor drug used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease. |
|
| DC10255 | Parecoxib | Parecoxib is a selective COX2 inhibitor. |
|
| DCAPI1503 | PARECOXIB SODIUM | PARECOXIB SODIUM |
|
| DC6577 | Paricalcitol | Paricalcitol |
|
| DC10893 | Parimifasor Featured | Parimifasor is an immunomodulator, with anti-inflammatory activity. |
|
| DC9098 | Paroxetine HCl Featured | Paroxetine hydrochloride hemihydrate is a antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). |
|
| DC9776 | Pazopanib Hydrochloride Featured | Pazopanib Hcl (GW-786034) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms with IC50 of 10 nM, 30 nM, 47 nM, 84 nM, 74 nM, 140 nM and 146 nM, respectively. |
|
| DC2600 | Pazopanib Featured | Pazopanib is a potent and selective multi-targeted receptor tyrosine kinase inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR-α/β, and c-Kit. |
|
| DC11100 | PBI-4050 sodium | PBI-4050 (Setogepram, PBI4050) is a synthetic analog of a medium-chain fatty acid that displays agonist and antagonist ligand affinity toward GPR40 and GPR84, respectively. |
|
| DC11099 | PBI-4050 | PBI-4050 (Setogepram, PBI4050) is a synthetic analog of a medium-chain fatty acid that displays agonist and antagonist ligand affinity toward GPR40 and GPR84, respectively. |
|
| DC9723 | PBTZ169 Featured | PBTZ169 is a decaprenyl-phosphoribose-epimerase (DprE1) inhibitor. |
|
| DC11770 | PC786 Featured | PC786 (PC-786) is a potent non-nucleoside RSV L-protein polymerase inhibitor with IC50 of 2.1 nM and 0.5 nM in cell-free enzyme assay and mini-genome assay in HEp-2 cells, respectively. |
|
| DC1106 | PCI-32765 (Ibrutinib) Featured | PCI-32765 (Ibrutinib) is a potent and highly selective Btk inhibitor with IC50 of 0.5 nM. |
|
| DC10531 | PCO371 Featured | PCO371 is a novel, orally active small molecule that acts as a full agonist of PTHR1. |
|
| DC7224 | PD 123319 Featured | PD 123319 is a potent, selective AT2 angiotensin II receptor antagonist with IC50 of 34 nM. |
|
| DC1056 | PD0325901 (Mirdametinib) Featured | PD0325901 (PD325901) is selective and non ATP-competitive MEK inhibitor with IC50 of 0.33 nM. |
|
| DC8168 | Peficitinib（ASP015K,JNJ-54781532） Featured | Peficitinib(ASP015K,JNJ-54781532) is a novel potent JAK inhibitor, which demonstrated potent efficacy in adjuvant-induced arthritis model in rats. |
|
| DC7225 | Pelitinib (EKB-569; WAY-EKB 569) Featured | Pelitinib (EKB-569; WAY-EKB 569) is a potent irreversible EGFR inhibitor with IC50 of 38.5 nM. |
|
| DC11360 | Pemafibrate Featured | Pemafibrate is an orally bioavailable and selective agonist of peroxisome proliferator-activated receptor α (PPARα; EC50 = 1 nM for transcriptional activity), a transcription factor that is essential for regulation of lipid homeostasis. |
|
| DC8149 | Pemetrexed disodium Featured | Pemetrexed disodium is a novel antifolate and antimetabolite for TS, DHFR and GARFT with Ki of 1.3 nM, 7.2 nM and 65 nM, respectively. |
|
| DCAPI1121 | Peramivir | Peramivir |
|
| DCAPI1010 | Peramivir Trihydrate Featured | Peramivir, also known as BCX1812 and RWJ 270201, is an antiviral drug for the treatment of influenza. Peramivir is a neuraminidase inhibitor, acting as a transition-state analogue inhibitor of influenza neuraminidase and thereby preventing new viruses from emerging from infected cells. Peramivir was approved to treat influenza infection in adults. |
|
| DC7226 | Perampanel(E2007） Featured | Perampanel(E2007; ER 155055-90) is a selective noncompetitive AMPA-type glutamate receptor antagonist which has demonstrated anticonvulsant activity in experimental seizure models and antiepileptic activity in clinical trials. |
|
| DC2021 | Perifosine (KRX-0401) Featured | Perifosine (KRX-0401) is a novel Akt inhibitor with IC50 of 4.7 μM. |
|
| DC10529 | PF 05089771 Featured | PF 05089771 is a Nav1.7 channel blocker extracted from patent WO/2010/079443 A1, compound example 788, has an IC50 of 8.6 nM. |
|
| DC8259 | PF0477736 Featured | PF 477736 is a CHK inhitor with Ki values of 0.49 and 47 nM for Chk1 and Chk2 respectively. A proprietary compound targeting cell cycle checkpoint kinase 1 (chk1) with potential chemopotentiation activity |
|
| DC11664 | PF-00446687 hydrochloride | PF-00446687 hydrochloride (PF-446687) is a potent, selective melanocortin-4 receptor (MC4R) agonist with EC50 of 12 nM. |
|
| DC11665 | PF-00446687 | PF-00446687(PF-446687) is a potent, selective melanocortin-4 receptor (MC4R) agonist with EC50 of 12 nM. |
|
